Cite
HARVARD Citation
Chang, G. et al. (2017). Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE study. Lung cancer. pp. 58-64. [Online].